Vanessa Vankerckhoven

Summary

Affiliation: University of Antwerp
Country: Belgium

Publications

  1. pmc Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium
    Vanessa Vankerckhoven
    Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium
    J Clin Microbiol 42:4473-9. 2004
  2. doi request reprint Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines
    Vanessa Vankerckhoven
    University of Antwerp, Vaccine and Infectious Disease Institute, Center for Evaluation of Vaccination, Universiteitsplein 1, Antwerp Wilrijk, Belgium
    Expert Opin Drug Deliv 7:1109-25. 2010
  3. pmc Genotypic diversity, antimicrobial resistance, and virulence factors of human isolates and probiotic cultures constituting two intraspecific groups of Enterococcus faecium isolates
    Vanessa Vankerckhoven
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    Appl Environ Microbiol 74:4247-55. 2008
  4. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009)
    Samuel Coenen
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi57-70. 2011
  5. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009)
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi47-56. 2011
  6. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009)
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi3-12. 2011
  7. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009)
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi37-45. 2011
  8. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009)
    Ann Versporten
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi25-35. 2011
  9. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi71-77. 2011
  10. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
    J Antimicrob Chemother 65:769-74. 2010

Collaborators

Detail Information

Publications21

  1. pmc Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium
    Vanessa Vankerckhoven
    Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium
    J Clin Microbiol 42:4473-9. 2004
    ..Molecular analysis showed the intrahospital spread of esp-positive VREF clones (in Italy) and hyl-positive VREF clones (in the United Kingdom); the role of hyl remains to be elucidated...
  2. doi request reprint Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines
    Vanessa Vankerckhoven
    University of Antwerp, Vaccine and Infectious Disease Institute, Center for Evaluation of Vaccination, Universiteitsplein 1, Antwerp Wilrijk, Belgium
    Expert Opin Drug Deliv 7:1109-25. 2010
    ..In addition, higher immune responses with the same quantity of antigen have been elicited with intradermal vaccine administration, offering dose-sparing capacity...
  3. pmc Genotypic diversity, antimicrobial resistance, and virulence factors of human isolates and probiotic cultures constituting two intraspecific groups of Enterococcus faecium isolates
    Vanessa Vankerckhoven
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610 Wilrijk, Belgium
    Appl Environ Microbiol 74:4247-55. 2008
    ..In combination with antimicrobial resistance and virulence testing, this grouping might represent an additional criterion in assessing the safety of new potential probiotic E. faecium isolates...
  4. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009)
    Samuel Coenen
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi57-70. 2011
    ....
  5. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009)
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi47-56. 2011
    ....
  6. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009)
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi3-12. 2011
    ..To describe total outpatient systemic antibiotic use in Europe from 1997 to 2009 and to analyse statistically trends of total use and composition of use over time...
  7. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009)
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi37-45. 2011
    ....
  8. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009)
    Ann Versporten
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi25-35. 2011
    ....
  9. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi71-77. 2011
    ..To assess quality of outpatient antibiotic use in Europe in 2009 based on the 12 European Surveillance of Antimicrobial Consumption (ESAC) drug-specific quality indicators and to evaluate changes in quality between 2004 and 2009...
  10. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
    J Antimicrob Chemother 65:769-74. 2010
    ..To assess the total outpatient systemic antimycotic and antifungal use in Europe, and to identify the antimycotic and antifungal substances most commonly used...
  11. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009)
    Ann Versporten
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:vi13-23. 2011
    ..Data on 13 years (1997-2009) of outpatient penicillin use were collected from 33 European countries within the European Surveillance of Antimicrobial Consumption (ESAC) project and analysed in detail...
  12. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe
    Niels Adriaenssens
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute VAXINFECTIO, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 66:1897-905. 2011
    ..To assess the total systemic antiviral use in Europe and to identify the antiviral substances most commonly used...
  13. doi request reprint The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide
    Ann Versporten
    Laboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium
    Pediatr Infect Dis J 32:e242-53. 2013
    ..This article describes the audit criteria used and reports overall country-specific proportions of antimicrobial use. An analytical review presents methodologies on antimicrobial use...
  14. ncbi request reprint Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis
    Vanessa Vankerckhoven
    Laboratory of Medical Microbiology, University of Antwerp, Belgium
    J Med Microbiol 56:1017-24. 2007
    ..Other disease-promoting factors may exist in these organisms and warrant further investigation...
  15. doi request reprint Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009
    Peter Zarb
    Infection Control Unit, Mater Dei Hospital, Msida, Malta
    J Antimicrob Chemother 66:443-9. 2011
    ..The main objective of this study was to identify and assess targets for quality improvement...
  16. pmc Differences in gut microbiota composition between obese and lean children: a cross-sectional study
    Liene Bervoets
    Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium
    Gut Pathog 5:10. 2013
    ..Secondly, associations between analysed gut bacterial species, dietary compounds, energy intake and biochemical blood parameters are evaluated...
  17. doi request reprint European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe
    Samuel Coenen
    Department of General Practice, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    J Antimicrob Chemother 64:200-5. 2009
    ..To assess the proportion of parenteral treatment of the total outpatient antibiotic use in Europe, and to identify the antibiotic groups and individual antibiotics most commonly administered in this way...
  18. doi request reprint Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome
    Annemieke Y Thijssen
    aDivision of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht bDepartment of Internal Medicine, Diaconessen Hospital Leiden, Leiden, The Netherlands cLaboratory of Medical Microbiology, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
    Eur J Gastroenterol Hepatol 28:8-14. 2016
    ..We aimed to assess the effect of the probiotic Lactobacillus casei Shirota (LcS) on symptoms and quality of life in IBS patients in a randomized, double-blind, placebo-controlled intervention study...
  19. ncbi request reprint Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use
    Geert Huys
    Laboratory of Microbiology, Ghent University, K L Ledeganckstraat 35, 9000 Ghent, Belgium
    Res Microbiol 157:803-10. 2006
    ..The current study has again highlighted that reliable identification of LAB and propionibacteria requires molecular methods with a high taxonomic resolution that are linked to up-to-date identification libraries...
  20. ncbi request reprint Safety assessment of Lactobacillus strains: presence of putative risk factors in faecal, blood and probiotic isolates
    Satu Vesterlund
    Department of Biochemistry and Food Chemistry and Functional Foods Forum, University of Turku, 20014 Turku, Finland
    Int J Food Microbiol 116:325-31. 2007
    ..However, the significance of adhesion to mucus, low induction of respiratory burst in PMN and resistance to human serum-mediated killing may need further evaluation in experimental animal models and in epidemiological data...
  21. ncbi request reprint Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use
    Ingo Klare
    Robert Koch Institute, Wernigerode Branch, Wernigerode, Germany
    J Antimicrob Chemother 59:900-12. 2007
    ..To propose tentative epidemiological cut-off (ECOFF) values for recognizing intrinsic and acquired antimicrobial resistances in numerically dominant species...